Formosa Pharmaceuticals, Inc. (TWSE: 6838)
Health Care · Pharmaceuticals · TW
NT$25.10
-0.79% today · -14.9% 1Y
Formosa Pharmaceuticals, Inc. (TWSE: 6838) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $118.52M.
Over the last twelve months the share price has lost 14.9%, trading between 22.35 and 33.30.
Tweenvest scores Formosa Pharmaceuticals, Inc. across four factors: quality 42/100, value 53/100. Its strongest factor is value.
6838 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $118.52M
- Revenue (TTM)
- $1.65M
- P/E
- —
- EPS
- -1.26
- Dividend yield
- —
- Beta (5Y)
- 0.62
- 52-week high
- NT$33.30
- 52-week low
- NT$22.35
- Avg volume (3M)
- —
- Shares outstanding
- 150.98M
- Employees
- —
- Next earnings
- —
About Formosa Pharmaceuticals, Inc.
Formosa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan. It is involved in developing TSY-110, an antibody-drug conjugate; and TSY-0210, an antibiotic for drug resistant infections. The company also develops APP13002 to treat infectious eye diseases, such as conjunctivitis, keratitis, blepharitis, and meibomian gland dysfunction; and MPT0E028, a novel pan- histone deacetylase inhibitor for solid tumors, such as hepatomas and colorectal cancer. It has a strategic partnership with Eyenovia, Inc. for the development of novel ophthalmic therapeutic; and Singapore Eye Research Institute to develop ophthalmic formulations for corneal diseases. Formosa Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Taipei City, Taiwan.
- ISIN
- TW0006838006
- Founded
- 2010
- Listed since
- Oct 7, 2021
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Semnur Pharmaceuticals, Inc.OTCPK: SMNR | $124.31M | $0.54 | +20.00% |
| T.Man Pharmaceutical Public Company LimitedSET: TMAN | $123.98M | ฿10.40 | -0.95% |
| NRx Pharmaceuticals, Inc.NasdaqCM: NRXP | $123.30M | $2.86 | +0.18% |
| KUKJEON Co.,LtdKOSDAQ: A307750 | $119.47M | ₩2,975.00 | +26.06% |
| Hyloris Pharmaceuticals SAENXTBR: HYL | $116.63M | €4.00 | +7.53% |
| Ilsung Is Co., Ltd.KOSE: A003120 | $115.86M | ₩22,350.00 | +1.36% |
| Lincoln Pharmaceuticals LimitedBSE: 531633 | $115.59M | Rs558.50 | -4.06% |
| Traphaco Joint Stock CompanyHOSE: TRA | $115.29M | ₫36,000.00 | -1.77% |
Figures last refreshed Oct 11, 2026.